In addition, we also found through a combination of genomic, transcriptomic, biological, clinical sample, and mouse model studies that the ceramide/β-catenin/SOAT1 signaling pathway was activated in both CRC patients and mice (Figure 8N). This evidence concerns the gene SOAT1 and colorectal carcinoma.